Kamada Ltd. Q1 Financial Results and Conference Call
Company Announcements

Kamada Ltd. Q1 Financial Results and Conference Call

Kamada Ltd (IL:KMDA) has released an update.

Kamada Ltd., a leading biopharmaceutical company, will unveil its financial outcomes for Q1 2024 on May 8 before the U.S. markets open and will host a conference call to discuss the results. The company, known for its specialty in plasma-derived products, has a significant commercial presence distributing FDA-approved biopharmaceuticals globally and is also progressing with an investigational inhaled AAT treatment in late-stage clinical trials.

For further insights into IL:KMDA stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyKamada initiated with a Buy at Stifel
TipRanks Auto-Generated NewsdeskKamada Ltd. Reports Strong Growth and Raises Guidance
TheFlyKamada raises FY24 revenue to $158M-$162M from $156M-$160M
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!